Yan Ming 13D and 13G filings for Cytek Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:08 pm Sale | 2023-12-31 | 13G | Cytek Biosciences, Inc. CTKB | Yan Ming | 6,203,867 4.700% | -1,999,491 (-24.37%) | Filing |
| 2022-02-14 2:01 pm Purchase | 2021-12-31 | 13G | Cytek Biosciences, Inc. CTKB | Yan Ming | 8,203,358 6.130% | 8,203,358 (New Position) | Filing |